GLP-1 & Muscle Loss: Evidence and Prevention GLP-1 receptor agonists such as semaglutide and liraglutide have transformed weight management for people with obesity, but concerns about muscle loss during treatment are increasingly common
Its crucial to know when to consult a doctor
Patients may be seen in Hollywood, FL, or by telehealth when appropriate
Research suggests that people who maintain a regular exercise routine after stopping GLP-1 medications may experience less weight regain
Mitochondrial-mediated ROS cause oxidative damage to cellular structures, particularly mitochondrial DNA, somatic mutations, genome instability, inactivation of tumor suppressor genes, alterations in metabolic and signaling pathways with simultaneous activation of compensatory antioxidant mechanisms, all of which contribute to cell transformation and thus promote various types of cancer [42]